Cencora (WBO:ABC) Other Operating Expense: €879 Mil (TTM As of Mar. 2026)


WBO:ABC Cencora Inc WBO:ABC
68 GF Score
Price €271.70
GF Value €256.66
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Cencora Other Operating Expense?

Cencora WBO:ABC +1.27% 68 Other Operating Expense is €879 Mil as of Mar. 2026. GuruFocus rates WBO:ABC with a GF Score™ of 68/100 and a GF Value™ of €256.66 (Fairly Valued). The stock has 1 warning sign investors should review.

Cencora's Other Operating Expense for the three months ended in Mar. 2026 was €216 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €879 Mil.

Cencora's quarterly Other Operating Expense increased from Sep. 2025 (€220 Mil) to Dec. 2025 (€222 Mil) but then declined from Dec. 2025 (€222 Mil) to Mar. 2026 (€216 Mil).

Cencora's annual Other Operating Expense increased from Sep. 2023 (€903 Mil) to Sep. 2024 (€984 Mil) but then declined from Sep. 2024 (€984 Mil) to Sep. 2025 (€896 Mil).

Cencora Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Cencora's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cencora Other Operating Expense Chart

Cencora Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 429.40 700.83 903.18 983.87 895.52

Cencora Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 240.33 220.21 220.47 222.38 215.64
WBO:ABC
68GF Score
Cencora Inc WBO:ABC
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cencora Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €879 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of €879 Mil mean?
Cencora (WBO:ABC) has a Other Operating Expense of €879 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Cencora and its competitors.
Is Cencora's Other Operating Expense too high?
Cencora's current Other Operating Expense is €879 Mil. Overall, Cencora has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Other Operating Expense compare to CAH and MCK?
Cencora's Other Operating Expense of €879 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Distribution company?
A good Other Operating Expense depends on the Medical Distribution industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Cencora and its competitors. Cencora's current Other Operating Expense is €879 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €256.66, compared to a current price of €271.70 — trading 5.9% above its estimated fair value. The current Other Operating Expense is €879 Mil. Cencora's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Other Operating Expense is €879 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cencora (WBO:ABC) Overvalued in 2026?

Based on GuruFocus' analysis, Cencora stock appears to be overvalued. The current stock price of €271.70 is trading 5.9% above its estimated GF Value™ of €256.66. GuruFocus considers Cencora to be Fairly Valued.

Key valuation signals for WBO:ABC:

  • Other Operating Expense: €879 Mil
  • GF Value™: €256.66 vs. price of €271.70 (5.9% above fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cencora Business Description

Address 1 West First Avenue, Conshohocken, PA, USA, 19428-1800
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
68GF Score

Get the complete analysis for WBO:ABC

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€271.70
Price
€256.66
GF Value